- Home
- GPRK vs CYRX Comparison
GPRK vs CYRX Comparison
Compare GPRK & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GPRK | CYRX |
|---|---|---|
| Founded | 2002 | 1999 |
| Country | Colombia | United States |
| Employees | N/A | 1100 |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.8M | 419.3M |
| IPO Year | 2009 | 2008 |
Fundamental Metrics
Financial Performance| Metric | GPRK | CYRX |
|---|---|---|
| Price | $9.91 | $9.95 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $8.50 | ★ $12.94 |
| AVG Volume (30 Days) | ★ 1.4M | 406.1K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | $39.45 | $11.06 |
| Revenue Next Year | N/A | $8.45 |
| P/E Ratio | $12.70 | ★ $6.89 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.75 | $5.21 |
| 52 Week High | $10.34 | $11.45 |
Technical Indicators
Market Signals| Indicator | GPRK | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 61.05 | 70.69 |
| Support Level | $7.84 | $9.18 |
| Resistance Level | $10.16 | $10.23 |
| Average True Range (ATR) | 0.53 | 0.42 |
| MACD | 0.03 | 0.19 |
| Stochastic Oscillator | 89.12 | 88.01 |
Price Performance
Historical ComparisonAbout GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.